Rayyan 记录了 1,116,437 月访问量，月度环比增长为 +7.9%，定价为免费增值。ValueSense 记录了 8,984 月访问量，增长率为 -25.4%，定价为免费增值。
Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.
让普通投资者也能用上对冲基金级别的估值与 AI 股票分析
| 维度 / 指标 | | |
|---|---|---|
| 官方域名 | rayyan.ai | valuesense.io |
| 定价模式 | 免费增值 | 免费增值 |
| 月访问量 | 111.64万 (1,116,437) | 8984 (8,984) |
| 月度环比流量变化 | +8.19万 (+7.9%) | -3052 (-25.4%) |
| 主要市场与份额 | 🇺🇸 美国 (18%) | 🇺🇸 美国 (36.1%) |
| 直接访问 / 月 | 67.79万 | 3654 |
| 用户评分 | 4.5 | 4.2 |
| 支持的平台 | 网站 | 网站 |
Rayyan is an AI-assisted systematic review platform that helps research teams import, deduplicate, screen, extract data from, and report on literature across the full evidence synthesis workflow.
The Systematic Auto-Resolver deduplicates up to 200,000 references using your own inclusion and exclusion protocol with one click.
ResearchPilot delivers zero-shot relevance ratings, an AI Analyzer, an AI Reviewer, and auto-extraction to speed up search, screening, and data capture.
Work through title, abstract, and full-text screening with inclusion and exclusion tagging, conflict resolution, and blinded reviewer modes.
Capture structured study data with configurable extraction fields, apply PICO frameworks, and export results with auto-generated PRISMA diagrams.
让普通投资者也能用上对冲基金级别的估值与 AI 股票分析
使用反向 DCF、DCF、彼得·林奇公允价值与盈利能力价值，在买入前估算股票的真正价值。
通过 AI 驱动的预设与自定义筛选器筛选市场，并回测筛选策略以查看其历史表现。
浏览护城河股、优质成长股与被低估标的等类别下 360 多个自动生成的股票创意，并定期更新。
追踪超级投资者的持仓以及内部人的买入与卖出，了解聪明资金的动向。
免费 / 开源Provides a completely free and open academic search database, but lacks collaborative literature review screening tools.
免费 / 开源Provides a completely free and open academic search database, but lacks collaborative literature review screening tools.
专项更强提供强大的引文分析与智能引文指标，但较不适合完整的 PRISMA 系统综述工作流。
专项更强Visualizes citation networks and paper relationships wonderfully, but lacks Rayyan's screening, tagging, and exclusion tracking features.
专项更强Visualizes citation networks and paper relationships wonderfully, but lacks Rayyan's screening, tagging, and exclusion tracking features.
专项更强Provides intuitive visual maps of academic literature connections, but doesn't support systematic review screening or data extraction.
专项更强Provides intuitive visual maps of academic literature connections, but doesn't support systematic review screening or data extraction.
提供扎实的文献搜索与参考文献管理工具，但缺乏 Rayyan 专门的协作筛选界面。
用于选股研究、筛选与市场信号的 AI 投资助手
专项更强按跑赢市场概率为每只股票排序的 AI 选股评分
专项更强Summarizes academic papers into interactive flashcards, but misses comprehensive systematic review screening pipelines.
专项更强以 AI 驱动的市场分析，让投资决策更快、更有数据依据
